47.56
price down icon3.39%   -1.67
after-market Handel nachbörslich: 47.21 -0.35 -0.74%
loading
Schlusskurs vom Vortag:
$49.23
Offen:
$48.25
24-Stunden-Volumen:
1.42M
Relative Volume:
1.07
Marktkapitalisierung:
$1.52B
Einnahmen:
$117.67M
Nettoeinkommen (Verlust:
$-1.88B
KGV:
-0.7856
EPS:
-60.5369
Netto-Cashflow:
$-621.36M
1W Leistung:
+3.00%
1M Leistung:
+26.83%
6M Leistung:
+165.40%
1J Leistung:
+216.01%
1-Tages-Spanne:
Value
$45.37
$48.94
1-Wochen-Bereich:
Value
$45.37
$52.56
52-Wochen-Spanne:
Value
$12.33
$63.99

Grail Inc Stock (GRAL) Company Profile

Name
Firmenname
Grail Inc
Name
Telefon
(833) 694-2553
Name
Adresse
1525 O'BRIEN DRIVE, MENLO PARK
Name
Mitarbeiter
1,000
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
GRAL's Discussions on Twitter

Vergleichen Sie GRAL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
GRAL
Grail Inc
47.56 1.52B 117.67M -1.88B -621.36M -60.54
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
427.76 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
202.50 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
542.71 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
120.66 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
164.65 27.64B 15.50B 1.33B 2.16B 7.34

Grail Inc Stock (GRAL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-21 Eingeleitet Canaccord Genuity Buy
2024-11-27 Eingeleitet Morgan Stanley Equal-Weight
2024-11-15 Eingeleitet Wolfe Research Peer Perform
2024-10-17 Eingeleitet Guggenheim Neutral

Grail Inc Aktie (GRAL) Neueste Nachrichten

pulisher
Jun 18, 2025

Grail plans to submit updated Galleri blood test for FDA approval next year - Fierce Biotech

Jun 18, 2025
pulisher
Jun 18, 2025

Grail stock gains on new data for Galleri cancer test (GRAL) - Seeking Alpha

Jun 18, 2025
pulisher
Jun 18, 2025

GRAIL reports positive results from cancer detection test study By Investing.com - Investing.com Nigeria

Jun 18, 2025
pulisher
Jun 18, 2025

GRAIL reports positive results from cancer detection test study - Investing.com Australia

Jun 18, 2025
pulisher
Jun 18, 2025

GRAIL Announces Positive Top-Line Results From The Galleri PATHFINDER 2 Registrational Study - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Grail reports results from PATHFINDER 2 study - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Revolutionary Cancer Screening Test Achieves Major Clinical Success: GRAIL's Galleri Outperforms Previous Study - Stock Titan

Jun 18, 2025
pulisher
Jun 17, 2025

GRAIL: Too Much A Leap Of Faith (NASDAQ:GRAL) - Seeking Alpha

Jun 17, 2025
pulisher
Jun 12, 2025

California State Teachers Retirement System Takes $464,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

67,288 Shares in Grail, Inc. (NASDAQ:GRAL) Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

NINGI short Grail, says ‘approval and commercialization all but impossible’ - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

GRAIL stock tumbles on short-seller report By Investing.com - Investing.com Nigeria

Jun 09, 2025
pulisher
Jun 09, 2025

GRAIL stock tumbles on short-seller report - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

Ningi Research Says Short Grail - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

3 Medical Technology Stocks Outperforming in 2025 - inkl

Jun 09, 2025
pulisher
Jun 08, 2025

GRALGRAIL Reports First Quarter 2025 Financial Results - mx.advfn.com

Jun 08, 2025
pulisher
Jun 08, 2025

Wellington Management Group LLP Takes Position in Grail, Inc. (NASDAQ:GRAL) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Two Sigma Advisers LP Makes New $345,000 Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

For FMCG Inc., the holy grail of volume growth is in sight | Company Business News - Mint

Jun 06, 2025
pulisher
Jun 05, 2025

Nuveen Asset Management LLC Takes $837,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Transcript : GRAIL, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 11 - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

BNP Paribas Financial Markets Invests $50,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Ameriprise Financial Inc. Takes $681,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

GRAIL, Inc. (GRAL) Stock Analysis: Evaluating the 19.10% Revenue Growth Against Market Challenges - DirectorsTalk Interviews

Jun 03, 2025
pulisher
Jun 03, 2025

96,630 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Two Sigma Investments LP - Defense World

Jun 03, 2025
pulisher
May 31, 2025

GRAIL announces inducement grants - Medical Buyer

May 31, 2025
pulisher
May 30, 2025

Grail Inc. stockholders elect director, ratify auditor By Investing.com - Investing.com Nigeria

May 30, 2025
pulisher
May 30, 2025

Grail Inc. stockholders elect director, ratify auditor - Investing.com

May 30, 2025
pulisher
May 30, 2025

GRAIL Inc Holds Annual Stockholders Meeting - TipRanks

May 30, 2025
pulisher
May 30, 2025

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire

May 30, 2025
pulisher
May 30, 2025

Grail (GRAL) and Its Competitors Head-To-Head Analysis - Defense World

May 30, 2025
pulisher
May 29, 2025

Rêve Health to Offer GRAIL’s Galleri® Multi-Cancer Early Detection Test - Fitt Insider

May 29, 2025
pulisher
May 29, 2025

Millennium Management LLC Takes $5.28 Million Position in Grail, Inc. (NASDAQ:GRAL) - Defense World

May 29, 2025
pulisher
May 27, 2025

(GRAL) Technical Data - news.stocktradersdaily.com

May 27, 2025
pulisher
May 27, 2025

Man Group plc Buys New Position in Grail, Inc. (NASDAQ:GRAL) - Defense World

May 27, 2025
pulisher
May 27, 2025

56,062 Shares in Grail, Inc. (NASDAQ:GRAL) Bought by Deutsche Bank AG - Defense World

May 27, 2025
pulisher
May 25, 2025

145,949 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Northern Trust Corp - Defense World

May 25, 2025
pulisher
May 25, 2025

Janus Henderson Group PLC Invests $223,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World

May 25, 2025
pulisher
May 24, 2025

595,962 Shares in Grail, Inc. (NASDAQ:GRAL) Bought by Bank of America Corp DE - Defense World

May 24, 2025
pulisher
May 21, 2025

Early Cancer Detection Pioneer GRAIL Reveals Latest Advances at Major Healthcare Conference - Stock Titan

May 21, 2025
pulisher
May 21, 2025

GRAIL to Present at Jefferies Global Healthcare Conference 2025 - PR Newswire

May 21, 2025
pulisher
May 19, 2025

Liquid Biopsy Market Is Booming So Rapidly | GRAIL, Freenome, Natera - openPR.com

May 19, 2025
pulisher
May 17, 2025

How to Take Advantage of moves in (GRAL) - news.stocktradersdaily.com

May 17, 2025
pulisher
May 16, 2025

Dimensional Fund Advisors LP Buys New Position in Grail, Inc. (NASDAQ:GRAL) - Defense World

May 16, 2025
pulisher
May 15, 2025

GRAIL falls 16% after Q1 topline miss - MSN

May 15, 2025
pulisher
May 15, 2025

GRAIL First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Biotech startup Grail (GRAL) gets grilled on its cash burn - Investorsobserver

May 15, 2025
pulisher
May 14, 2025

Gravity study shows why the moon's two sides look so different - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Health Care Sector Slips While Incannex Rockets Ahead - Finimize

May 14, 2025
pulisher
May 14, 2025

Sector Update: Health Care - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

GRAIL and athenahealth partner to simplify ordering of cancer detection test - MSN

May 14, 2025

Finanzdaten der Grail Inc-Aktie (GRAL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research DGX
$176.60
price down icon 1.52%
diagnostics_research WAT
$351.92
price down icon 1.43%
diagnostics_research LH
$260.00
price down icon 1.61%
$161.57
price up icon 0.53%
diagnostics_research MTD
$1,205.65
price up icon 0.03%
diagnostics_research IQV
$164.65
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):